WO2001019405A3 - Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung - Google Patents

Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung Download PDF

Info

Publication number
WO2001019405A3
WO2001019405A3 PCT/EP2000/009004 EP0009004W WO0119405A3 WO 2001019405 A3 WO2001019405 A3 WO 2001019405A3 EP 0009004 W EP0009004 W EP 0009004W WO 0119405 A3 WO0119405 A3 WO 0119405A3
Authority
WO
WIPO (PCT)
Prior art keywords
nanoparticles
magnetic
intracellular
nuclear particle
production
Prior art date
Application number
PCT/EP2000/009004
Other languages
English (en)
French (fr)
Other versions
WO2001019405A2 (de
Inventor
Michael K Bahr
Dimitri Berkov
Norbert Buske
Joachim Clement
Peter Goernert
Klaus Hoeffken
Kay-Oliver Kliche
Thomas Kober
Matthias Schnabelrauch
Sebastian Vogt
Kerstin Wagner
Christian Gansau
Original Assignee
Biomedical Apherese Systeme Gm
Michael K Bahr
Dimitri Berkov
Norbert Buske
Joachim Clement
Peter Goernert
Klaus Hoeffken
Kliche Kay Oliver
Thomas Kober
Matthias Schnabelrauch
Sebastian Vogt
Kerstin Wagner
Christian Gansau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedical Apherese Systeme Gm, Michael K Bahr, Dimitri Berkov, Norbert Buske, Joachim Clement, Peter Goernert, Klaus Hoeffken, Kliche Kay Oliver, Thomas Kober, Matthias Schnabelrauch, Sebastian Vogt, Kerstin Wagner, Christian Gansau filed Critical Biomedical Apherese Systeme Gm
Priority to EP00979466A priority Critical patent/EP1216060A2/de
Priority to AU16943/01A priority patent/AU1694301A/en
Priority to US10/088,437 priority patent/US6767635B1/en
Priority to BR0014252-2A priority patent/BR0014252A/pt
Priority to JP2001523036A priority patent/JP2003509034A/ja
Priority to CA002384429A priority patent/CA2384429A1/en
Publication of WO2001019405A2 publication Critical patent/WO2001019405A2/de
Publication of WO2001019405A3 publication Critical patent/WO2001019405A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Abstract

Die Erfindung bezieht sich auf magnetische Nanoteilchen, ihre Herstellung sowie auf ihre Verwendung. Aufgabe der Erfindung ist die Bereitstellung von Nanoteilchen, die spezifisch auch im intrazellulären Bereich von Zellen Bindungen an intrazelluläre Biomakromoleküle eingehen können, so daß durch Einwirkung eines äußeren Magnetfeldes eine Separation möglich wird. Die Lösung erfolgt durch magnetische Nanoteilchen mit biochemischer Wirksamkeit, bestehend aus einem magnetischen Kernteilchen und einer am Kernteilchen fixierten Hüllschicht, enthaltend eine Verbindung der allgemeinen Formel M - S - L - Z (I), wobei die Verknüpfungsstellen zwischen S und L und L und Z kovalent gebundene funktionelle Gruppen aufweisen und wobei M das magnetische Kernteilchen, S ein an M fixiertes, biokompatibles Substrat, L eine Linker-Gruppierung ist und Z eine Gruppierung, bestehend aus Nukleinsäuren, Peptiden oder Proteinen oder deren Derivate, die mindestens eine Struktur aufweist, die spezifisch mit einer Bindungsdomäne eines intrazellulären Biomakromoleküls zur Bindung befähigt ist, ist.
PCT/EP2000/009004 1999-09-14 2000-09-14 Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung WO2001019405A2 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP00979466A EP1216060A2 (de) 1999-09-14 2000-09-14 Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung
AU16943/01A AU1694301A (en) 1999-09-14 2000-09-14 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
US10/088,437 US6767635B1 (en) 1999-09-14 2000-09-14 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
BR0014252-2A BR0014252A (pt) 1999-09-14 2000-09-14 Nanopartìculas magnéticas tendo atividade bioquìmica, método para sua produção e seus usos
JP2001523036A JP2003509034A (ja) 1999-09-14 2000-09-14 生化学活性を有する磁性ナノ粒子、その製造法と使用
CA002384429A CA2384429A1 (en) 1999-09-14 2000-09-14 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944971.6 1999-09-14
DE19944971 1999-09-14

Publications (2)

Publication Number Publication Date
WO2001019405A2 WO2001019405A2 (de) 2001-03-22
WO2001019405A3 true WO2001019405A3 (de) 2002-04-11

Family

ID=7922617

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/009004 WO2001019405A2 (de) 1999-09-14 2000-09-14 Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung

Country Status (9)

Country Link
US (1) US6767635B1 (de)
EP (1) EP1216060A2 (de)
JP (1) JP2003509034A (de)
CN (1) CN1379687A (de)
AU (1) AU1694301A (de)
BR (1) BR0014252A (de)
CA (1) CA2384429A1 (de)
DE (1) DE10046508A1 (de)
WO (1) WO2001019405A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883423B2 (en) 2010-10-22 2014-11-11 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689338B2 (en) 2000-06-01 2004-02-10 The Board Of Regents For Oklahoma State University Bioconjugates of nanoparticles as radiopharmaceuticals
DE10108857A1 (de) * 2001-02-14 2002-09-19 Hans-Dieter Hunger Bioaktive und biokompatible Konjugate mit magnetischen Eigenschaften und Verfahren zu deren Herstellung
US20030092029A1 (en) * 2001-06-06 2003-05-15 Lee Josephson Magneitc-nanoparticle conjugates and methods of use
ATE536993T1 (de) * 2002-01-02 2011-12-15 Visen Medical Inc Aminfunktionalisierte superparamagnetisierte nanoteilchen für die synthese von biokonjugaten
CN1646549A (zh) * 2002-02-04 2005-07-27 财团法人理工学振兴会 结合铁氧体的有机物及其制备方法
DE60320780D1 (de) 2002-04-22 2008-06-19 Univ Florida Funktionalisierte nanopartikel und verwendungsverfahren
GB2393728A (en) * 2002-10-04 2004-04-07 Nanomagnetics Ltd Magnetic nanoparticles
EP1631259A4 (de) 2002-12-18 2006-08-02 Hough Ear Inst Otologische nanotechnologie
DE10331439B3 (de) * 2003-07-10 2005-02-03 Micromod Partikeltechnologie Gmbh Magnetische Nanopartikel mit verbesserten Magneteigenschaften
US20040161862A1 (en) * 2003-02-15 2004-08-19 Golovlev Valeri V. Method of visualization and quantification of biopolymer molecules immobilized on solid support
US20080050842A1 (en) * 2003-02-15 2008-02-28 Golovlev Valeri V Method of visualization and quanitification of biopolymer molecules immobilized on solid support
GB0313259D0 (en) 2003-06-09 2003-07-16 Consejo Superior Investigacion Magnetic nanoparticles
US8651113B2 (en) * 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7723311B2 (en) * 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
JP4422982B2 (ja) * 2003-06-24 2010-03-03 日立マクセル株式会社 生体物質結合用磁性担体
JP2005060221A (ja) * 2003-07-31 2005-03-10 Rikogaku Shinkokai 有機物質とフェライトとの複合材料とその製造方法
WO2005044836A2 (de) 2003-11-05 2005-05-19 Genovoxx Gmbh Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
US7208134B2 (en) * 2003-12-18 2007-04-24 Massachusetts Institute Of Technology Bioprocesses enhanced by magnetic nanoparticles
CN100333715C (zh) * 2004-01-02 2007-08-29 孙永海 定向损毁脊神经后根用磁性药物微球及其制备方法
JP4646003B2 (ja) * 2004-02-03 2011-03-09 旭化成株式会社 磁気ビーズを用いた被検物質の検出方法
US9028829B2 (en) * 2004-02-20 2015-05-12 The Children's Hospital Of Philadelphia Uniform field magnetization and targeting of therapeutic formulations
US8562505B2 (en) * 2004-02-20 2013-10-22 The Children's Hospital Of Philadelphia Uniform field magnetization and targeting of therapeutic formulations
US7846201B2 (en) * 2004-02-20 2010-12-07 The Children's Hospital Of Philadelphia Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex
CN100340299C (zh) * 2004-06-22 2007-10-03 北京倍爱康生物技术股份有限公司 一种体内用放射性核素磁性微球的制备方法
KR100604976B1 (ko) * 2004-09-03 2006-07-28 학교법인연세대학교 다작용기 리간드로 안정화된 수용성 나노입자
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7462446B2 (en) * 2005-03-18 2008-12-09 University Of Washington Magnetic nanoparticle compositions and methods
US7781228B2 (en) 2005-04-07 2010-08-24 Menon & Associates, Inc. Magnetic resonance system and method to detect and confirm analytes
DE102005016873A1 (de) * 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
DE602006020710D1 (de) * 2005-04-22 2011-04-28 Fred Hutchinson Cancer Res Foundation Fluoreszentes chlorotoxinkonjugat und verfahren zur intraoperativen sichtbarmachung von krebs
EP2385386B1 (de) * 2005-05-09 2012-11-14 The General Hospital Corporation Magnetresonanzsensoren zum Beobachten der Konzentration eines Analyten
WO2006123686A1 (ja) 2005-05-20 2006-11-23 Jsr Corporation 担体ポリマー粒子およびその製造方法ならびに特異捕捉用磁性粒子およびその製造方法
JP2007085929A (ja) * 2005-09-22 2007-04-05 Jsr Corp 特異捕捉用磁性粒子およびその製造方法
JP5295769B2 (ja) * 2005-08-31 2013-09-18 ティツー・バイオシステムズ・インコーポレーテッド 分析物を検出するためのｎｍｒ装置
KR100731913B1 (ko) 2005-09-20 2007-06-25 한양대학교 산학협력단 생체분자 검출용 나노하이브리드 입자의 제조방법, 나노하이브리드 입자를 이용한 생체분자 검출기, 생체분자 검출 방법 및 생체분자 검출용 분석장치
KR100851933B1 (ko) * 2005-12-02 2008-08-12 연세대학교 산학협력단 망간 산화물 나노입자를 포함하는 자기공명 영상제
EP1973575B1 (de) 2005-12-22 2019-07-24 Visen Medical, Inc. Biokompatibele fluoreszierende metalloxide nanopartikel
US20070166730A1 (en) 2006-01-19 2007-07-19 Menon & Associates, Inc. Magnetic resonance system and method to detect and confirm analytes
KR100713745B1 (ko) * 2006-02-27 2007-05-07 연세대학교 산학협력단 상전이 리간드로 코팅된 수용성 자성 또는 금속 산화물나노입자 및 이의 제조방법
US20090216320A1 (en) * 2006-04-21 2009-08-27 The Children's Hospital Of Philadelphia Magnetic Gradient Targeting And Sequestering Of Therapeutic Formulations And Therapeutic Systems Thereof
JP2010502992A (ja) * 2006-09-05 2010-01-28 コロンバス ナノワークス，インコーポレーテッド 磁性粒子、並びにその作製及び使用方法
US8368402B2 (en) 2006-11-08 2013-02-05 T2 Biosystems, Inc. NMR systems for in vivo detection of analytes
US8501159B2 (en) * 2006-12-18 2013-08-06 Colorobbia Italia S.P.A. Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
EP2128095A4 (de) * 2007-01-05 2011-12-21 Tokyo Inst Tech Sphärisches ferrit-nanopartikel und herstellungsverfahren dafür
US8017031B2 (en) * 2007-01-15 2011-09-13 Institute Of Chemistry, Chinese Academy Of Sciences Biocompatible magnetic nanocrystal, powder of a biocompatible magnetic nanocrystal bearing a surface reactive group and preparations thereof
JP5313906B2 (ja) * 2007-04-12 2013-10-09 インダストリー−アカデミック コーペレイション ファウンデイション， ヨンセイ ユニバーシティ 亜鉛が含有された金属酸化物磁性ナノ粒子を含む磁気共鳴映像剤
US9097644B2 (en) 2007-08-17 2015-08-04 Massachusetts Institute Of Technology Magnetic resonance-based viscometers and methods
WO2009026251A1 (en) * 2007-08-17 2009-02-26 The General Hospital Corporation Detecting ions and measuring ion concentrations
EP2201398A1 (de) 2007-09-28 2010-06-30 T2 Biosystems, Inc. Nmr-diagnostika mit probenbehälter aus kunststoff
WO2009061481A1 (en) 2007-11-06 2009-05-14 T2 Biosystems, Inc. Small magnet and rf coil for magnetic resonance relaxometry
US9011913B2 (en) * 2008-04-04 2015-04-21 The Regents Of The University Of California Use of functionalized magnetic nanoparticles in cancer detection and treatment
EP2265174B1 (de) 2008-04-04 2018-06-06 The Regents of The University of California Funktionalisierte magnetische nanoteilchen und anwendungsverfahren
US9182391B2 (en) * 2008-05-09 2015-11-10 Arkray, Inc. Method of producing insoluble carrier particles, insoluble carrier particles, measurement reagent, specimen analyzing tool, and immunoturbidimetric assay
AU2009246142A1 (en) 2008-05-15 2009-11-19 Transmolecular, Inc. Treatment of metastatic tumors
JP5326443B2 (ja) 2008-09-05 2013-10-30 Ｊｎｃ株式会社 凍結乾燥可能な温度応答性磁性微粒子
AU2009308841B2 (en) 2008-10-29 2014-07-17 T2 Biosystems, Inc. NMR detection of coagulation time
US20120058480A1 (en) * 2009-02-24 2012-03-08 Lewis Dorothy E Antigenic approach to the detection and isolation of microparticles associated with fetal dna
US9845237B2 (en) * 2009-02-26 2017-12-19 The Regents Of The University Of California Supramolecular approach for preparation of size controllable nanoparticles
US20100260686A1 (en) * 2009-04-09 2010-10-14 Washington, University Of Nanoparticles for brain tumor imaging
US20110024683A1 (en) * 2009-08-03 2011-02-03 E. I. Du Pont De Nemours And Company Method for controlling the size of rare-earth-doped fluoride nanoparticles - ii
EP2494073B1 (de) 2009-10-26 2017-11-29 AGCT GmbH Konjugate von nukleotiden und methoden zu deren anwendung
US8565892B2 (en) 2009-10-31 2013-10-22 Qteris, Inc. Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment
US9018347B2 (en) 2010-02-04 2015-04-28 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
CN102190701B (zh) * 2010-03-05 2013-01-23 西北大学 一种流感病毒血凝素大规模分离纯化方法
KR101972173B1 (ko) 2010-05-11 2019-04-24 프레드 헛친슨 켄서 리서치 센터 클로로톡신 변이체, 접합체, 및 이의 사용 방법
KR101642939B1 (ko) * 2010-08-31 2016-07-26 한화케미칼 주식회사 산화철 나노캡슐, 이의 제조방법 및 이를 포함하는 자기공명영상진단 조영제
US8563298B2 (en) 2010-10-22 2013-10-22 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
AU2011317073B2 (en) 2010-10-22 2016-04-07 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
TWI415940B (zh) * 2010-12-20 2013-11-21 Univ Kaohsiung Medical 超順磁氧化物與聚乙烯二胺複合式磁性錯合物的奈米粒子作為基因轉染載體
EP2505558B1 (de) 2011-03-28 2013-01-16 King Saud University Verfahren zur Herstellung von magnetischen Verbindungen (Fe3O4) und Derivate daraus
EP3345545B1 (de) 2011-04-21 2021-10-20 The Regents of The University of California Funktionalisierte magnetische nanoteilchen und ihre verwendung bei der abbildung von amyloider plaque und neurofibrillären bündeln
DE102012008375A1 (de) 2011-04-27 2012-10-31 Genovoxx Gmbh Methoden und Komponenten zur Detektion von Nukleinsäureketten
CN103917658B (zh) 2011-07-13 2016-09-21 T2生物系统公司 用于监测血块形成的nmr方法
CN102408288B (zh) * 2011-08-10 2013-12-18 天津市天地创智科技发展有限公司 应用蛋白质功能化磁性纳米颗粒拆分手性药物的方法
CN102408289B (zh) * 2011-08-10 2014-03-12 天津市天地创智科技发展有限公司 一种应用蛋白质功能化磁性纳米颗粒拆分手性药物的方法
WO2013043858A1 (en) 2011-09-21 2013-03-28 T2 Biosystems, Inc. Nmr methods for endotoxin analysis
BR112014009753B1 (pt) * 2011-10-21 2020-09-15 Stemgenics, Inc Nanopartícula biocompatível funcionalizada e respectivo uso
US9562271B2 (en) 2012-04-20 2017-02-07 T2 Biosystems, Inc. Compositions and methods for detection of Candida species
FI125322B (en) 2012-06-11 2015-08-31 Planmeca Oy Tooth Surface Models
WO2014089346A1 (en) 2012-12-07 2014-06-12 T2 Biosystems, Inc. Methods for monitoring tight clot formation
US20140179560A1 (en) 2012-12-10 2014-06-26 Fred Hutchinson Cancer Research Center Drug discovery methods and platforms
WO2014143383A1 (en) 2013-03-13 2014-09-18 Agilent Technologies, Inc. Transposome tethered to a gene delivery vehicle
US9784730B2 (en) 2013-03-21 2017-10-10 University Of Washington Through Its Center For Commercialization Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine
EP2804186B1 (de) 2013-05-14 2017-12-27 King Saud University Beschichtete magnetitnanopartikel
WO2014206424A1 (en) * 2013-06-24 2014-12-31 Zaghloul Mohammad Hosam Eldeen Trapping magnetic nanoparticles by cyclin b1 mrna scaffold
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
EP3109637B1 (de) * 2014-02-10 2019-08-14 JSR Corporation Verfahren zur erfassung einer zielsubstanz, festphasenträger zur er einer zielsubstanz und verfahren zur herstellung eines festphasenträgers
DE102014019388A1 (de) * 2014-12-29 2016-06-30 Susanne Wagner Arzneimittel auf der Basis von Maghämit zur gleichzeitigen Reduzierung der gastrointestinalen Natriumresorption und Phosphatresorption
DE102015003113A1 (de) 2015-03-06 2016-09-08 Friedrich-Schiller-Universität Jena Beschichtete Magnetpartikel für die Separation biologischer Zellen und Verfahren zu deren Herstellung
AU2017210033B2 (en) 2016-01-21 2022-09-29 T2 Biosystems, Inc. NMR methods and systems for the rapid detection of bacteria
WO2017204209A1 (ja) * 2016-05-24 2017-11-30 Jsr株式会社 複合粒子、被覆粒子、複合粒子の製造方法、リガンド含有固相担体および試料中の標的物質を検出または分離する方法
CN106039324B (zh) * 2016-07-12 2019-08-30 北京理工大学 一种装载siRNA的仿生型磁小体及其制备方法
EP3523008A4 (de) 2016-10-05 2020-05-20 Khalifa University of Science and Technology Verfahren zur entfernung von hitzebeständigen salzen von lösungsmitteln
CN108314786B (zh) * 2018-05-07 2020-10-02 信阳师范学院 一种齿状聚合物、利用其修饰氧化铁纳米颗粒的方法及由该方法得到的产品
CA3155347A1 (en) * 2019-10-22 2021-04-29 Benjamin Shapiro Lipid coated iron oxide nanoparticles for otitis media
CN112034159B (zh) * 2020-09-06 2023-08-29 武汉生之源生物科技股份有限公司 一种凝胶化免疫磁珠及其制备方法与用途
CN115739042A (zh) * 2022-11-07 2023-03-07 浙江大学 一种表面修饰磁性纳米颗粒及分离水中多价噬菌体的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056288A1 (de) * 1999-03-19 2000-09-28 Institut Für Neue Materialien Gem. Gmbh Nanoskalige teilchen, komplexe mit polynukleotiden und deren verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665582A (en) * 1990-10-29 1997-09-09 Dekalb Genetics Corp. Isolation of biological materials
US5248589A (en) * 1991-02-21 1993-09-28 Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Separation of cells and biological macromolecules by ferritin conjugates
US6548264B1 (en) * 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US6521773B1 (en) * 2000-07-21 2003-02-18 James F. Hainfeld Extended organic cobalt and nickel magnetic complexes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056288A1 (de) * 1999-03-19 2000-09-28 Institut Für Neue Materialien Gem. Gmbh Nanoskalige teilchen, komplexe mit polynukleotiden und deren verwendung

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; SHI, KEYU ET AL: "Magnetic drug delivery system - adriamycin-carboxymethyl dextran magnetic nanoparticles", XP002183998, retrieved from STN Database accession no. 133:140083 *
MYKHAYLYK, O. ET AL: "Glial brain tumor targeting of magnetite nanoparticles in rats", J. MAGN. MAGN. MATER. (2001), 225(1-2), 241-247, XP001041592 *
SHENGWU YIXUE GONGCHENGXUE ZAZHI (2000), 17(1), 21-24 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883423B2 (en) 2010-10-22 2014-11-11 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
US9360457B2 (en) 2010-10-22 2016-06-07 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes

Also Published As

Publication number Publication date
AU1694301A (en) 2001-04-17
JP2003509034A (ja) 2003-03-11
WO2001019405A2 (de) 2001-03-22
US6767635B1 (en) 2004-07-27
CA2384429A1 (en) 2001-03-22
BR0014252A (pt) 2002-11-19
DE10046508A1 (de) 2001-04-05
EP1216060A2 (de) 2002-06-26
CN1379687A (zh) 2002-11-13

Similar Documents

Publication Publication Date Title
WO2001019405A3 (de) Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung
WO2006066598A3 (en) Antibody binding affinity ligands
WO2004004647A3 (en) Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes
WO2001002551A3 (en) Virus like particles, preparation and use in screening and functional genomics
WO2002012501A3 (en) Anti-dual integrin antibodies, compositions, methods and uses
CA2200735A1 (en) Chromatographic resins and methods for using same
WO2001074898A3 (en) Charged compounds comprising a nucleic acid binding moiety and uses therefor
WO1999019730A3 (en) Stable protein-nickel particles and methods of production and use thereof
WO2002002783A3 (en) Expression vectors
CA2349948A1 (en) A chromatography method and a column material useful in said method
EP2105449A3 (de) Antagonistische selektive Bindemittel eines Osteoprotegerin-bindenden Proteins
WO2001047959A3 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO2003046200A3 (en) Methods for ligand discovery
WO2004024750A3 (en) Cd44-binding ligands
AU2002254892A1 (en) Sorting and immobilization system for nucleic acids using synthetic bidning systems
WO2000042179A3 (de) Komplexbildende proteine
AU2826801A (en) Surface modified supporting materials for binding biological materials, method for the production and use thereof
EP1944321A3 (de) Verfahren und Verbindungen zur Bestimmung der Reinheit von chemisch synthetisierten Nukleinsäuren
EP1023906A4 (de) Verstärker für antikörper gegen lymphoiden tumor
WO2005014823A3 (en) Targeted carrier fusions for delivery of chemotherapeutic agents
WO2003022433A3 (en) A derivatized macrocycle compound for covalent bonding to a substrate and method of forming and use
WO2000059942A3 (en) Human obesity protein binding protrein-2 homolog and uses thereof
WO2001001142A3 (en) Arrays of biopolymeric agents and method for their production and use
CA2385766A1 (en) Methods for production of proteins in host cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 16943/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2384429

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 523036

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 008137072

Country of ref document: CN

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000979466

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10088437

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000979466

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000979466

Country of ref document: EP